Submitted by Anonymous (not verified) on 14 October 2025 - 16:08
Opinion/decision on a Paediatric investigation plan (PIP): Nulojix, belatacept, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0351/2024
Source: